STEREOSELECTIVE METABOLISM OF THE 5-LIPOXYGENASE INHIBITOR A-78773

[1] THE EFFECT OF AN INHALED LEUKOTRIENE ANTAGONIST, L-648,051, ON EARLY AND LATE ASTHMATIC REACTIONS AND SUBSEQUENT INCREASE IN AIRWAY RESPONSIVENESS IN MAN [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (06) : 1067 - 1075

[2] THE PROPERTIES OF A-69412 - A SMALL HYDROPHILIC 5-LIPOXYGENASE INHIBITOR [J]. AGENTS AND ACTIONS, 1993, 38 (3-4): : 178 - 187

[3] BELL RL, 1993, J LIPID MEDIATOR, V6, P259

[4] Britton J, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17B, P1003

[5] CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929

[6] THE POTENT AND SELECTIVE SULFIDOPEPTIDE LEUKOTRIENE ANTAGONIST, SK-AND-F-104353, INHIBITS ASPIRIN-INDUCED ASTHMA [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04): : 957 - 958

[7] A SPECIFIC LTD4 LTE4-RECEPTOR ANTAGONIST IMPROVES PULMONARY-FUNCTION IN PATIENTS WITH MILD, CHRONIC ASTHMA [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (05): : 1336 - 1339

[8] DAHLEN B, 1993, EUR RESPIR J, V6, P1018

[9] DAHLEN SE, 1991, ADV PROSTAG THROMB L, V21, P461

[10] EFFECT OF THE ORAL LEUKOTRIENE ANTAGONIST, ICI 204,219, ON ANTIGEN-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH ASTHMA [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (05) : 1040 - 1045

[1] THE EFFECT OF AN INHALED LEUKOTRIENE ANTAGONIST, L-648,051, ON EARLY AND LATE ASTHMATIC REACTIONS AND SUBSEQUENT INCREASE IN AIRWAY RESPONSIVENESS IN MAN [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (06) : 1067 - 1075

[2] THE PROPERTIES OF A-69412 - A SMALL HYDROPHILIC 5-LIPOXYGENASE INHIBITOR [J]. AGENTS AND ACTIONS, 1993, 38 (3-4): : 178 - 187

[3] BELL RL, 1993, J LIPID MEDIATOR, V6, P259

[4] Britton J, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17B, P1003

[5] CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929

[6] THE POTENT AND SELECTIVE SULFIDOPEPTIDE LEUKOTRIENE ANTAGONIST, SK-AND-F-104353, INHIBITS ASPIRIN-INDUCED ASTHMA [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04): : 957 - 958

[7] A SPECIFIC LTD4 LTE4-RECEPTOR ANTAGONIST IMPROVES PULMONARY-FUNCTION IN PATIENTS WITH MILD, CHRONIC ASTHMA [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (05): : 1336 - 1339

[8] DAHLEN B, 1993, EUR RESPIR J, V6, P1018

[9] DAHLEN SE, 1991, ADV PROSTAG THROMB L, V21, P461

[10] EFFECT OF THE ORAL LEUKOTRIENE ANTAGONIST, ICI 204,219, ON ANTIGEN-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH ASTHMA [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (05) : 1040 - 1045